Surrey researchers Sign in
Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents
Journal article

Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents

HM Coley, CF Shotton, A Ajose-Adeogun, H Modjtahedi and H Thomas
BIOCHEMICAL PHARMACOLOGY, Vol.72(8), pp.941-948
16/10/2006

Abstract

Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy PHARMACOLOGY & PHARMACY receptor tyrosine kinase inhibition ovarian cancer EGFR expressing drug resistance EPIDERMAL-GROWTH-FACTOR CARCINOMA CHEMOTHERAPY ACTIVATION ANTIBODIES MUTATIONS GEFITINIB SURVIVAL ALPHA ACTS
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241067300003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Usage Policy